TYROSINE PHOSPHORYLATION OF CD19 IN PRE-B-CELLS AND MATURE B-CELLS

被引:79
作者
CHALUPNY, NJ
KANNER, SB
SCHIEVEN, GL
WEE, SF
GILLILAND, LK
ARUFFO, A
LEDBETTER, JA
机构
[1] The Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, WA 98121
关键词
ACTIVATION; SH2; DOMAIN; SIGNALING;
D O I
10.1002/j.1460-2075.1993.tb05930.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cross-linking of B cell surface immunoglobulins (sIg) results in activation of mature B cells and stimulates a molecular signaling mechanism for antigen-specific B cell expansion and differentiation. This signaling pathway is dependent on tyrosine (Tyr) phosphorylation and results in the activation of sIg-associated src family kinases and p72SYK. Rapid Tyr phosphorylation occurs on multiple protein substrates. Here we show that activation of B cells by cross-linking sIg results in an increase in Tyr phosphorylation of the lineage-restricted B cell surface antigen CD19, and show that it is a major substrate of activated Tyr kinase following sIg stimulation. Lower levels of constitutive CD19 Tyr phosphorylation occurred in most sIg+ mature B cell lines examined and in normal dense tonsillar B cells. We also rind that when CD19 is Tyr-phosphorylated it becomes competent to interact with SH2 domains suggesting a mechanism whereby, following B cell activation, CD19 could be linked to intracellular signaling pathways. In sIg- pre-B cell lines, CD19 was expressed but was not constitutively phosphorylated on tyrosine. Upon CD19 cross-linking, Tyr phosphorylation of CD19 was induced in sIg- pre-B cell lines. CD19 cross-linking also directly induced Tyr phosphorylation of CD19 and other substrates in mature B cells. The ability of CD19 to signal in the absence of sIg expression may provide important stimulation in pre-B cell development.
引用
收藏
页码:2691 / 2696
页数:6
相关论文
共 50 条
[41]   B-cells in systemic sclerosis: emerging evidence from genetics to phenotypes [J].
Wu, Minghua ;
Mohan, Chandra .
CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (06) :537-541
[42]   Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells [J].
Godbersen, J. Claire ;
Paiva, Cody ;
Danilova, Olga V. ;
Berger, Allison ;
Brown, Jennifer R. ;
Danilov, Alexey V. .
LEUKEMIA & LYMPHOMA, 2015, 56 (05) :1566-1569
[43]   B-cell Expansion and Lymphomagenesis Induced by Chronic CD40 Signaling Is Strictly Dependent on CD19 [J].
Hojer, Caroline ;
Frankenberger, Samantha ;
Strobl, Lothar J. ;
Feicht, Samantha ;
Djermanovic, Kristina ;
Jagdhuber, Franziska ;
Hoemig-Hoelzel, Cornelia ;
Ferch, Uta ;
Ruland, Juergen ;
Rajewsky, Klaus ;
Zimber-Strobl, Ursula .
CANCER RESEARCH, 2014, 74 (16) :4318-4328
[44]   Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance [J].
Nguyen, Tue G. ;
Little, Christopher B. ;
Yenson, Vanessa M. ;
Jackson, Christopher J. ;
McCracken, Sharon A. ;
Warning, Julia ;
Stevens, Veronica ;
Gallery, Eileen G. ;
Morris, Jonathan M. .
JOURNAL OF AUTOIMMUNITY, 2010, 35 (01) :86-97
[45]   A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome [J].
Detsika, Maria G. ;
Ampelakiotou, Kleio ;
Grigoriou, Eirini ;
Psarra, Katherina ;
Jahaj, Edison ;
Roussos, Charis ;
Dimopoulou, Ioanna ;
Orfanos, Stylianos E. ;
Tsirogianni, Alexandra ;
Kotanidou, Anastasia .
VIROLOGY, 2021, 556 :79-86
[46]   Signaling pathways leading to apoptosis or survival in immature and mature B cells [J].
Sármay, G ;
Koncz, G ;
Bodor, C ;
Kövesdi, D ;
Gáti, R ;
Gergely, J .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :181-185
[47]   Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis [J].
Zhang, Tengfei ;
Cao, Ling ;
Xie, Jing ;
Shi, Ni ;
Zhang, Zhen ;
Luo, Zhenzhen ;
Yue, Dongli ;
Zhang, Zimeng ;
Wang, Liping ;
Han, Weidong ;
Xu, Zhongwei ;
Chen, Hu ;
Zhang, Yi .
ONCOTARGET, 2015, 6 (32) :33961-33971
[48]   Evaluation of CD19+CD5+B (B1) Lymphocytes and CD20+CD38 Low Preplasmablast Cells in Patients with Behcet's Disease [J].
Kandi, Basak ;
Ilhan, Fulya ;
Cicek, Demet ;
Demir, Nesrin ;
Bulut, Vedat ;
Ucak, Haydar ;
Halisdemir, Nurhan .
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (06) :1521-1526
[49]   Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19 [J].
Szili, Daniel ;
Cserhalmi, Marcell ;
Banko, Zsuzsanna ;
Nagy, Gyoergy ;
Szymkowski, David E. ;
Sarmay, Gabriella .
MABS, 2014, 6 (04) :991-999
[50]   Dysfunction of CD19+ CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid [J].
Liu, Zhenfeng ;
Dang, Erle ;
Li, Bing ;
Qiao, Hongjiang ;
Jin, Liang ;
Zhang, Jieyu ;
Wang, Gang .
SCIENTIFIC REPORTS, 2018, 8